Michael T. Constantino - Net Worth and Insider Trading
Michael T. Constantino Net Worth
The estimated net worth of Michael T. Constantino is at least $67,308 dollars as of 2024-09-20. Michael T. Constantino is the Director of Humacyte Inc and owns about 12,350 shares of Humacyte Inc (HUMA) stock worth over $67,308. Michael T. Constantino is also the Director of 9 Meters Biopharma Inc and owns about 3,025 shares of 9 Meters Biopharma Inc (NMTRQ) stock worth over $0. Details can be seen in Michael T. Constantino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael T. Constantino has not made any transactions after 2024-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael T. Constantino
Michael T. Constantino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael T. Constantino owns 2 companies in total, including 9 Meters Biopharma Inc (NMTRQ) , and Humacyte Inc (HUMA) .
Click here to see the complete history of Michael T. Constantino’s form 4 insider trades.
Insider Ownership Summary of Michael T. Constantino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma Inc | 2022-05-23 | director |
| HUMA | Humacyte Inc | 2024-08-15 | director |
Michael T. Constantino Latest Holdings Summary
Michael T. Constantino currently owns a total of 2 stocks. Among these stocks, Michael T. Constantino owns 12,350 shares of Humacyte Inc (HUMA) as of August 15, 2024, with a value of $67,308 and a weighting of 100%. Michael T. Constantino also owns 3,025 shares of 9 Meters Biopharma Inc (NMTRQ) as of May 23, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Michael T. Constantino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HUMA | Humacyte Inc | 2024-08-15 | 12,350 | 5.45 | 67,308 |
| NMTRQ | 9 Meters Biopharma Inc | 2022-05-23 | 3,025 | 0.00 | 0 |
Holding Weightings of Michael T. Constantino
Michael T. Constantino Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael T. Constantino has made a total of 4 transactions in Humacyte Inc (HUMA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Humacyte Inc is the acquisition of 3,100 shares on August 15, 2024, which cost Michael T. Constantino around $19,499.
According to the SEC Form 4 filings, Michael T. Constantino has made a total of 4 transactions in 9 Meters Biopharma Inc (NMTRQ) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in 9 Meters Biopharma Inc is the acquisition of 800 shares on May 23, 2022, which cost Michael T. Constantino around $7,680.
Insider Trading History of Michael T. Constantino
- 1
Michael T. Constantino Trading Performance
GuruFocus tracks the stock performance after each of Michael T. Constantino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael T. Constantino is -6.23%. GuruFocus also compares Michael T. Constantino's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael T. Constantino within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael T. Constantino's insider trading performs compared to the benchmark.
Performance of Michael T. Constantino
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.09 | | | | | |
| Relative Return to S&P 500(%) | -13.25 | | | | | |
Michael T. Constantino Ownership Network
Michael T. Constantino Owned Company Details
What does 9 Meters Biopharma Inc do?
Who are the key executives at 9 Meters Biopharma Inc?
Michael T. Constantino is the director of 9 Meters Biopharma Inc. Other key executives at 9 Meters Biopharma Inc include Chief Financial Officer Bethany Sensenig , director & Chief Executive Officer John Temperato , and Chief Financial Officer Edward J Sitar .
9 Meters Biopharma Inc (NMTRQ) Insider Trades Summary
Over the past 18 months, Michael T. Constantino made no insider transaction in 9 Meters Biopharma Inc (NMTRQ). Other recent insider transactions involving 9 Meters Biopharma Inc (NMTRQ) include a net sale of 9,100 shares made by Bethany Sensenig ,
In summary, during the past 3 months, insiders sold 0 shares of 9 Meters Biopharma Inc (NMTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,100 shares of 9 Meters Biopharma Inc (NMTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,100 shares.
9 Meters Biopharma Inc (NMTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
9 Meters Biopharma Inc Insider Transactions
Michael T. Constantino Mailing Address
Above is the net worth, insider trading, and ownership report for Michael T. Constantino. You might contact Michael T. Constantino via mailing address: C/o 9 Meters Biopharma, Inc., 8480 Honeycutt Road, Suite 120, Raleigh Nc 27615.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
